TMO - Thermo Fisher Scientific Inc Stock Analysis
Thermo Fisher Scientific Inc (TMO) is a publicly traded company listed on the NYSE. It operates in the Diagnostics & Research industry, part of the broader Healthcare sector. The company has a market capitalization of 232.46B, generates annual revenue of 43.74B, and reports net income of 6.57B. As of the latest data, the stock is trading at 618.72 USD.
From a valuation and risk perspective, the stock presents the following profile: The stock is moderately valued and aligns with market expectations for established companies. The PEG ratio is above 2, which could imply the stock is overvalued based on its growth outlook. The company maintains a healthy balance between debt and equity, which is typical for stable businesses. The dividend yield (0.27%) is modest, often associated with growth-oriented companies. The stock has average market volatility, aligning with general market movement.
Analyst recommendation stands at Buy (4.16), indicating current market sentiment. Institutional ownership is reported at 91.55%, reflecting confidence from large investors. Over the last 12 months, the stock has shown a performance of 12.19%, trading within a 52-week range of 385.46 - 629.87.
TMO - Thermo Fisher Scientific Inc
618.72
Analyst Consensus
Buy 4.16
TMO – Analyst Rating Summary
- Strong Buy: 9
- Buy: 19
- Hold: 4
- Sell: 0
- Strong Sell: 0
- Total Analysts: 32
| Index: | S&P 500 | P/E: | 35.75 | EPS (ttm): | 17.31 | Insider Own: | 0.23% | Shs Outstand: | 375.71M | Perf Week: | -0.02% |
| Market Cap: | 232.46B | Forward P/E: | 25.14 | EPS next Y: | 24.61 | Insider Trans: | -17.39% | Shs Float: | 374.83M | Perf Month: | 8.52% |
| Income(ttm): | 6.57B | PEG: | 3.34 | EPS next Q: | 6.45 | Inst Own: | 91.55% | Short Float: | 1.04% | Perf Quarter: | 15.27% |
| Revenue(ttm): | 43.74B | P/S: | 5.32 | EPS this Y: | 4.04% | Inst Trans: | 0.22% | Short Ratio: | 2.14 | Perf Half Y: | 49.18% |
| Book/sh: | 135.79 | P/B: | 4.56 | EPS next Y: | 8.21% | ROA: | 6.46% | Short Interest: | 3.90M | Perf Year: | 12.19% |
| Cash/sh: | 9.46 | P/C: | 65.43 | EPS next 5Y: | 7.52% | ROE: | 13.14% | 52W Range: | 385.46 - 629.87 | Perf YTD: | 6.78% |
| Dividend Est.: | 1.67 (0.27%) | P/FCF: | 38.04 | EPS past 3/5Y: | -5.27% 12.52% | ROIC: | 7.93% | 52W High: | 629.87 -1.77% | Beta: | 0.93 |
| Dividend TTM: | 1.72 (0.28%) | Quick Ratio: | 1.11 | Sales past 3/5Y: | 3.03% 10.92% | Gross Margin: | 40.53% | 52W Low: | 385.46 60.51% | Perf 5Y: | 20.53% |
| Dividend Ex-Date: | Dec 15, 2025 | Current Ratio: | 1.50 | EPS Y/Y TTM: | 8.26% | Oper. Margin: | 18.77% | RSI (14): | 61.89 | Volatility: | 2.71% 2.16% |
| Employees: | 125000 | Debt/Eq: | 0.70 | Sales Y/Y TTM: | 3.22% | Profit Margin: | 15.02% | Recom: | 1.52 | Target Price: | 656.47 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 0.62 | EPS Q/Q: | 0.71% | Payout: | 9.43% | Rel Volume: | 1.58 | Prev Close: | 624.65 |
| Sales Surprise: | 1.87% | EPS Surprise: | 5.32% | Sales Q/Q: | 4.94% | Earnings: | Jan 29 BMO | Avg Volume: | 1.82M | Price: | 618.72 |
| SMA20: | 3.57% | SMA50: | 5.70% | SMA200: | 26.04% | Undervalued: 6.1% | Volume: | 2,870,441 | Change: | -0.95% | |
Graham Classic formula value: 365.9
(P/E=8 * 1g) Min value: 241.24
(current P/E * 2g) Max value: 789.46
Average value: 465.53
About Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. serves the scientific community through a broad offering of innovative products and services. Thermo Fisher Scientific serves customers working in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental, industrial, research and development, quality and process control settings. The company's global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through its brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. The company continuously increases its depth of capabilities across its broad portfolio of innovative products and services and leverages its extensive global channels to address customers' needs. The company does this through organic investments in research and development, capacity and capabilities and through acquisitions. The company's goal is to enable its customers to be more productive in an increasingly competitive business environment, enable them to accelerate innovation, solve their challenges and advance their important work. The company's history roots back to the year 1956 when the business was first established. Thermo Fisher Scientific was formed in 2006 from the merger of Thermo Electron and Fisher Scientific and is headquartered in Waltham, MA.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.